Cargando…
Evaluation of liposomal ciprofloxacin formulations in a murine model of anthrax
The in vivo efficacy of liposomal encapsulated ciprofloxacin in two formulations, lipoquin and apulmiq, were evaluated against the causative agent of anthrax, Bacillus anthracis. Liposomal encapsulated ciprofloxacin is attractive as a therapy since it allows for once daily dosing and achieves higher...
Autores principales: | Stratilo, Chad W., Jager, Scott, Crichton, Melissa, Blanchard, James D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6980410/ https://www.ncbi.nlm.nih.gov/pubmed/31978152 http://dx.doi.org/10.1371/journal.pone.0228162 |
Ejemplares similares
-
Inhaled Liposomal Ciprofloxacin Protects against a Lethal Infection in a Murine Model of Pneumonic Plague
por: Hamblin, Karleigh A., et al.
Publicado: (2017) -
The potential of liposome–encapsulated ciprofloxacin as a tularemia therapy
por: Hamblin, Karleigh A., et al.
Publicado: (2014) -
Decontamination Efficacy and Skin Toxicity of Two Decontaminants against Bacillus anthracis
por: Stratilo, Chad W., et al.
Publicado: (2015) -
Development of Liposomal Ciprofloxacin to Treat Lung Infections
por: Cipolla, David, et al.
Publicado: (2016) -
A New Murine Model for Gastrointestinal Anthrax Infection
por: Xie, Tao, et al.
Publicado: (2013)